Skip to main content
Pharmena S.A. logo

Pharmena S.A. — Investor Relations & Filings

Ticker · PHR ISIN · PLPHRMN00011 LEI · 259400RHT936BBKW0955 WAR Manufacturing
Filings indexed 649 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country PL Poland
Listing WAR PHR

About Pharmena S.A.

https://www.pharmena.eu/

Pharmena S.A. is a specialty healthcare company focused on the development and commercialization of innovative products based on its patented active ingredient, 1-MNA. This molecule is a naturally occurring metabolite of niacin (vitamin B3) that plays a crucial role in cellular metabolism. The company's technology leverages the ability of 1-MNA to optimize the levels of the coenzyme NAD+, which decline with age and are vital for cellular function and regeneration. The product portfolio includes specialized cosmeceuticals, such as the Dermena line for hair loss, and dietary supplements designed to address the effects of cellular aging.

Recent filings

Filing Released Lang Actions
zal05_Oswiadczenie_Jacek_Szwajcowski.pdf
Regulatory Filings Classification · 90% confidence The document is a personal statement by a nominee consenting to serve on the Supervisory Board. It contains no financial data, no corporate announcement of actual board appointments, no formal meeting materials, and no report itself. It is a standalone statutory declaration filed with the regulator or exchange, which does not fit into any specific category. Therefore, it is best classified under the general ‘Regulatory Filings’ category (RNS).
2026-05-20 Polish
zal01_20260520_Informacja_dot_Jacka_Szwajcowskiego.pdf
Board/Management Information Classification · 93% confidence The document announces the appointment of Jacek Szwajcowski as a member of the Supervisory Board, provides his start date, role, qualifications and other positions. This is a clear announcement of a change in the company’s board/senior management. It fits the Board/Management Information category.
2026-05-20 Polish
zal07_Oswiadczenie_Zbigniew_Molenda.pdf
Regulatory Filings Classification · 85% confidence The document is a candidate’s written consent to stand for election and serve on the Supervisory Board of PHARMENA S.A., containing legal compliance attestations (independence criteria, no convictions, no conflicts). It does not announce actual board appointments, present financial data, or form part of an AGM presentation packet, nor is it a proxy solicitation. It is a standalone regulatory-compliance statement and thus best fits into the general Regulatory Filings (RNS) category as a miscellaneous compliance filing.
2026-05-20 Polish
zal06_20260520_Informacja_dot_Zbigniewa_Molenda.pdf
Board/Management Information Classification · 90% confidence The document provides detailed information on the appointment of Zbigniew Molenda as a member of the Supervisory Board, outlining his appointment date, function, qualifications, and other positions, which aligns with an announcement of changes in the company's board. This fits the Board/Management Information category.
2026-05-20 Polish
zal08_Oswiadczenie_Anna_Paczkowska.pdf
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a personal statement of consent by a nominee for the supervisory board, disclosing independence and eligibility criteria as required for shareholder voting materials. It is not a financial report or an announcement of an actual board change, but part of the proxy solicitation materials for the election of board members. Therefore it fits the Proxy Solicitation & Information Statement category (PSI).
2026-05-20 Polish
zal12_20260520_Informacja_dot._Anny_Paczkowskiej.pdf
Board/Management Information Classification · 92% confidence The document provides detailed personal and professional information about Anna Paczkowska’s appointment as a member of the Supervisory Board, referencing the relevant disclosure regulation (§10 of Minister of Finance Regulation). This is an announcement of a board appointment, fitting the definition of Board/Management Information (MANG).
2026-05-20 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.